| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Pontifax Management 4 G.P. (2015) Ltd. is a 10% Owner at LB PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 9 buys and 4 sells.
Estimated insider holdings value: $45.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | KROS Keros Therapeutics, Inc. | 10% Owner | Sell | 4,787,331 | $17.75 | $84,975,125.25 | -100% | +34.6% | - | |
| Sep 12, 2025 | LBRX Lb Pharmaceuticals Inc | 10% Owner | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +242.9% | +20.4% | - | |
| Nov 17, 2020 | KROS Keros Therapeutics, Inc. | 10% Owner | Buy | 60,000 | $50.00 | $3,000,000.00 | +1.3% | - | - | |
| Apr 13, 2020 | KROS Keros Therapeutics, Inc. | 10% Owner | Buy | 437,499 | $16.00 | $6,999,984.00 | +10.2% | - | - |